Ivalua Named a Visionary in 2016 Gartner Magic Quadrant for Procure-to-Pay Suites
Positioned Furthest for Completeness of Vision in the Visionaries Quadrant
Redwood City, USA – 29 June 2016 – Ivalua Inc., the leading global spend management solutions provider, today announced it has been positioned by Gartner, Inc. in the “Visionaries” Quadrant of its 2016 Magic Quadrant for Procure-to-Pay Suites*. Among Visionaries, Ivalua is positioned the furthest along the completeness of vision axis.
“We consider our positioning in the Magic Quadrant for P2P Suites by Gartner as confirmation of Ivalua‘s success in delivering advanced, market-leading Spend Management solutions,” said David Khuat-Duy, Ivalua CEO.
Gartner evaluated twelve Procure-to-Pay application providers specifically on completeness of vision and ability to execute.
“We feel our continuous effort to deliver innovative solutions, balanced with usability, performance and agility has been recognized,” said Dan Amzallag, CEO, Ivalua Inc.
“I congratulate Ivalua for being named a P2P Visionary by Gartner. CACI utilizes the Ivalua platform to manage its vast supplier base and all of its overarching supplier contracts and purchase orders. The ease of the application allows suppliers to manage their company information, receive awards, and submit invoices all within a single application, making the supplier adoption process a success”, said Steven H. Weiss, Executive Vice President, Government Business Operations, CACI.
*Gartner, Magic Quadrant for Procure-to-Pay Suites, Deborah R Wilson, Paolo Malinverno, Magnus Bergfors, Desere Edwards. Published 13 June 2016
Disclaimer – Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.